Headquartered in Dublin, Ireland, Novaerus has developed the most significant advancement in infection control and prevention in more than 100 years. Novaerus has taken plasma technology to the next frontier by applying it to the air and killing harmful microorganisms.
Novaerus is the first and only scientifically proven system for airborne infection control. By drawing air through the clinically proven and patented Air Plasma Field, Novaerus devices immediately destroy viruses, bacteria, VOC's and odour in the air. This creates a safer, healthier and odour-free environment - all the while using less energy than a 40watt light bulb. These characteristics have all been thoroughly tested in clinical trials and scientific research - tests, for example in the NASA Ames laboratories in California showed that Novaerus achieved higher bacterial kill rates in milliseconds than traditional heat sterilisation could over 2 hours. Developed for use in hospitals, nursing homes, assisted living facilities and other healthcare facilities, Novaerus provides significant health, environmental and cost benefits to patients, staff and visitors in these facilities.
Novaerus is the next revolution in infection control. It has developed the most significant advancement in infection control and prevention in more than 100 years. Novaerus’s Plasma Air Technology is the first and only scientifically proven system for airborne infection control.
ISO 9001 ISO 14001 ISO 18001 Complies to UL867 CE Certificate of Conformity EMC Certificate
• Healthcare (Hospitals, Nursing Homes)
Over 200 healthcare facilities in USA and Europe
Distribution partners globally
Europe, Middle East and Africa (EMEA), United States of America (USA), France, Germany, Netherlands, United Kingdom (UK)
DCU Innovation Centre Glasnevin Dublin 11
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.